天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
400-158-6606
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook >> CAS DataBase List >> FILGRASTIM

FILGRASTIM

FILGRASTIM price.
  • $220
  • Product name: FILGRASTIM
  • CAS: 121181-53-1
  • MF: W99
  • MW: 0
  • EINECS:
  • MDL Number:MFCD01771574
  • Synonyms:FILGRASTIM;n-l-methionyl-colony-stimulatingfactor(humanclone1034 ;Colony-stiMulating factor (huMan clone 1034), N-L-Methionyl- (9CI);Filgrastim CRS;FILGRASTIM USP/EP/BP;Filgrastim DISCONTINUED;Figrastim;filgrastimconcentratedSolution
1 prices
Selected condition:
Brand
  • Sigma-Aldrich
Package
  • y0001173
  • ManufacturerSigma-Aldrich
  • Product numberY0001173
  • Product descriptionFilgrastim European Pharmacopoeia (EP) Reference Standard
  • Packagingy0001173
  • Price$220
  • Updated2024-03-01
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Sigma-Aldrich Y0001173 Filgrastim European Pharmacopoeia (EP) Reference Standard y0001173 $220 2024-03-01 Buy

Properties

storage temp. :-70°C

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H361 Suspected of damaging fertility or the unborn child Reproductive toxicity Category 2 Warning P201, P202, P281, P308+P313, P405,P501
Precautionary statements:
P201 Obtain special instructions before use.
P202 Do not handle until all safety precautions have been read and understood.
P281 Use personal protective equipment as required.
P308+P313 IF exposed or concerned: Get medical advice/attention.
P405 Store locked up.
P501 Dispose of contents/container to..…

Description

Filgrastim is a recombinant human granulocyte colony stimulating factor (G-CSF) indicated as an adjunct to cancer chemotherapy for patients with non-myeloid malignancies. It reduces the duration of chemotherapy-induced neutropenia by forcing immature leucocytes to differentiate into neutrophils, thereby decreasing the incidence and length of infections.Bone pain is the most significant side effect.Chugai launched the second G-CSF, lenograstim, in December 1991. Other potential uses include bone marrow transplants, myelodysplastic syndromes and febrilelchronic neutropenia.

Related product price